These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37267802)

  • 1. Heterogeneous distribution pattern of CD3+ tumor-infiltrated lymphocytes (TILs) and high combined positive score (CPS) favored the prognosis of resected early stage small-cell lung cancer.
    Zhu L; Cheng G; Wu M; Chen M; Jin Y
    Transl Oncol; 2023 Aug; 34():101697. PubMed ID: 37267802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution characteristics and prognosis of tumor-infiltrating lymphocytes in the brain metastases of small cell lung cancer: a retrospective cohort study.
    Qian H; Pang J; Wan C; Mei X; Liao J; Wang B; Milano MT; Suwinski R; Inno A; Du Y
    Transl Cancer Res; 2024 May; 13(5):2509-2517. PubMed ID: 38881925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-9-based immune risk score model helps to predict relapse in stage I-III small cell lung cancer.
    Chen P; Zhang L; Zhang W; Sun C; Wu C; He Y; Zhou C
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33082168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of PD-1 and PD-L1 on Tumor-Infiltrating Lymphocytes Predicts Prognosis in Patients with Small-Cell Lung Cancer.
    Sun C; Zhang L; Zhang W; Liu Y; Chen B; Zhao S; Li W; Wang L; Ye L; Jia K; Wang H; Wu C; He Y; Zhou C
    Onco Targets Ther; 2020; 13():6475-6483. PubMed ID: 32753888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I-III small cell lung cancer.
    Chen P; Zhao L; Wang H; Zhang L; Zhang W; Zhu J; Yu J; Zhao S; Li W; Sun C; Wu C; He Y; Zhou C
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34362829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD39: the potential target in small cell lung cancer.
    Chen S; Wu S; Zhang L; Zhang W; Liu Y; Chen B; Zhao S; Li W; Sun C; Wang L; Jia K; Wang H; Chen P; Wu C; Zhu J; He Y; Zhou C
    Transl Lung Cancer Res; 2020 Aug; 9(4):1483-1495. PubMed ID: 32953520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).
    Berghoff AS; Ricken G; Wilhelm D; Rajky O; Widhalm G; Dieckmann K; Birner P; Bartsch R; Preusser M
    J Neurooncol; 2016 Oct; 130(1):19-29. PubMed ID: 27436101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
    Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III.
    Jiang M; Wu C; Zhang L; Sun C; Wang H; Xu Y; Sun H; Zhu J; Zhao W; Fang Q; Yu J; Chen P; Wu S; Zheng Z; He Y; Zhou C
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34006632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of CD8 in the tumor microenvironment is associated with PD-1 expression and patient survival in high-grade serous ovarian cancer.
    Ölmez F; Oğlak SC; Ölmez ÖF; Akbayır Ö; Yılmaz E; Akgöl S; Konal M; Seyhan NA; Kinter AK
    Turk J Obstet Gynecol; 2022 Sep; 19(3):246-256. PubMed ID: 36149309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of PD-L1 and CD4+ tumor-infiltrating lymphocytes predict survival in head and neck squamous cell carcinoma.
    Fu ZM; Zhang DJ; Guo YY; Han S; Guo F; Bai J; Wan YN; Guan GF; Sun KW; Yang N
    Mol Clin Oncol; 2022 Mar; 16(3):59. PubMed ID: 35111324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance.
    Xin H; Zhou C; Wang G; Liu Y; Zhang J; Liu Y; Li B; Zhang J; Su M; Li Z; Wang G
    Heliyon; 2023 Feb; 9(2):e13048. PubMed ID: 36814622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of PD-L1 protein expression and CD8
    Sun Y; Zhai C; Chen X; Dong Z; Hou L; Zhou C; Jiang T
    Transl Lung Cancer Res; 2019 Dec; 8(6):748-759. PubMed ID: 32010554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance of PD-L1 expression and CD8+ TIL intensity between NSCLC and synchronous brain metastases.
    Batur S; Dulger O; Durak S; Yumuk PF; Caglar HB; Bozkurtlar E; Bozkurt S; Tastekin E; Cicin I; Ahiskali R; Rzazade R; Cakir A; Oz B
    Bosn J Basic Med Sci; 2020 Aug; 20(3):329-335. PubMed ID: 31999935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages.
    Kono-Sato T; Miyai K; Yamagishi Y; Miyamoto M; Takano M; Matsukuma S; Sato K; Tsuda H
    BMC Cancer; 2022 Apr; 22(1):361. PubMed ID: 35366828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical Resection of SCLC: Prognostic Factors and the Tumor Microenvironment.
    Zhao X; Kallakury B; Chahine JJ; Hartmann D; Zhang Y; Chen Y; Zhang H; Zhang B; Wang C; Giaccone G
    J Thorac Oncol; 2019 May; 14(5):914-923. PubMed ID: 30735815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance, Correlation, and Clinical Impact of Standardized PD-L1 and TIL Scoring in SCCHN.
    De Keukeleire SJ; Vermassen T; Deron P; Huvenne W; Duprez F; Creytens D; Van Dorpe J; Ferdinande L; Rottey S
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological correlation of PD-L1 and TET1 expression with tumor-infiltrating lymphocytes in non-small cell lung cancer.
    Ahn H; Lee HJ; Lee JH; Cho HD; Oh MH; Son JW; Jang SH
    Pathol Res Pract; 2020 Nov; 216(11):153188. PubMed ID: 32919305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive relevance of PD-L1 expression with pre-existing TILs in gastric cancer.
    Ju X; Shen R; Huang P; Zhai J; Qian X; Wang Q; Chen M
    Oncotarget; 2017 Nov; 8(59):99372-99381. PubMed ID: 29245908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.